Abstract:Background: Gene fusions, resulting from chromosomal rearrangements, play a critical role in the oncogenesis of various cancers, often acting as diagnostic markers and therapeutic targets. Their detection is important for understanding tumor biology and guiding personalized treatment strategies. With the evolution of economical sequencing technologies, hypothesis-free gene fusion detection in cancer genomics is becoming more accessible. This study demonstrates the use of the cost-effective Ultima Genomics UG100 platform for a comprehensive analysis of gene fusions, uniquely integrating Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS). This integration capitalizes on the strengths of both methods: WGS, which enables a broad analysis of structural variations including extragenic events, and WTS for more functional characterization of expressed gene fusions and abnormal isoforms, offering a synergistic approach that enhances the detection and characterization of genomic rearrangements. Methods: Five cancer cell lines (K562, THP-1, NCI-H660, Kasumi-1, MV4-11) with 29 previously detected gene fusions were sequenced, using both WTS and WGS, in addition to a standard fusion reference sample (Seraseq Fusion RNA Mix, with 16 RNA fusions). The libraries were sequenced on a UG100 sequencer using single ended reads of length ~250bp and analyzed with publicly available software: STAR-Fusion, combined with FusionInspector were used to detect RNA fusions; Manta and GridSS were used to detect DNA structural variations, including translocations. Results: 93% of the documented fusion events were detected in DNA and in RNA, in addition to the 16 evaluated just in RNA (100% detected). Sequence data from both WTS and WGS on the UG100 platform successfully identified a spectrum of gene fusions in both DNA and RNA, thereby confirming the platform's detection capabilities in both types of assays. The structural variation events detected in the WGS were comprised mainly of translocations, but also deletions and duplications. Conclusions: The Ultima Genomics UG100 sequencer has proven to be a cost-effective and efficient tool for the genome-wide discovery and validation of gene fusions, which can be impactful in clinical oncology settings. This study underscores the potential of using an integrated WTS and WGS approach on a single platform to advance our understanding of the genomic complexity of cancer, paving the way for more effective diagnostic and therapeutic strategies. Citation Format: Gila Lithwick-Yanai, Sarah Pollock, Danit Lebanony, Keren Ben Simhon, Sima Benjamin, David Bogumil, Nika Iremadze, Matt Sexton, Peleg Winer, Maya Levy, Shlomit Gilad, Josh Haimes, Giulia Corbet, Jennifer Pavlica, Doron Lipson. Cost-effective, comprehensive detection of gene fusions from DNA and RNA using the UG100 sequencer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 315.

Enhanced Detection of Novel Low‐Frequency Gene Fusions via High‐Yield Ligation and Multiplexed Enrichment Sequencing

A Nanopore Sequencing-Based Assay for Rapid Detection of Gene Fusions

Simultaneous Detection of Gene Fusions and Base Mutations in Cancer Tissue Biopsies by Sequencing Dual Nucleic Acid Templates in Unified Reaction.

An optimized workflow of full-length transcriptome sequencing for accurate fusion transcript identification

One-step and Highly Sensitive Quantification of Fusion Genes with Isothermal Amplification Initiated by a Fusion-Site Anchored Stem-Loop Primer

Selective multiplexed enrichment for the detection and quantitation of low-fraction DNA variants via low-depth sequencing

SEGF: A Novel Method for Gene Fusion Detection from Single-End Next-Generation Sequencing Data

Development of coupling controlled polymerizations by adapter-ligation in mate-pair sequencing for detection of various genomic variants in one single assay.

Detecting Ultra Low-Frequency Variants and Gene Fusions in Lung Cancer Patients Using an Amplicon-Based Firefly NGS Method.

Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens

LongGF: Computational Algorithm and Software Tool for Fast and Accurate Detection of Gene Fusions by Long-Read Transcriptome Sequencing

SeekFusion - A Clinically Validated Fusion Transcript Detection Pipeline for PCR-Based Next-Generation Sequencing of RNA

Extended Enrichment for Ultrasensitive Detection of Low‐Frequency Mutations by Long Blocker Displacement Amplification

Real-time Quantification of Fusion Transcripts with Ligase Chain Reaction by Direct Ligation of Adjacent DNA Probes at Fusion Junction

Systematic analysis of actionable gene fusions by NGS-based in pancancer for precision oncology in China.

Highly Sensitive Enrichment of Low-Frequency Variants by Hairpin Competition Amplification

Sensitive detection of fusion transcripts with padlock probe-based continuous cascade amplification (P-CCA)

Abstract 7418: LongFuse: Detecting gene fusion transcripts from high throughput long-read single cell RNA sequencing data

Integrated Dual-Biomarker Detection: Transforming Proteins and Nucleic Acids into Ssdna for Enhanced Disease Diagnosis

Abstract 315: Cost-effective, comprehensive detection of gene fusions from DNA and RNA using the UG100 sequencer

FusionQ: a Novel Approach for Gene Fusion Detection and Quantification from Paired-End RNA-Seq.